Male osteoporosls in Spain;Osteoporosis en el varón en España

Revista Espanola de Enfermedades Metabolicas Oseas

Volumn 12, Issue 1, 2003, Pages 1-3

  Diaz Curiel M ^a   Espinoza Pineda, J ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BONE FRAGILITY; EDITORIAL; EXERCISE; HUMAN; MALE; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; SEX DIFFERENCE; SPAIN; VERTEBRA FRACTURE;

EID: 0038709608     PISSN: 11328460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. Seeman E. The dilemma of osteoporosis in men. Am J Med 1995;98(2A):76S-88S.
2. Díaz Curiel M, Carrasco de la Peña JL, Honorato Pérez J, Pérez Cano R, Rapado A, Ruiz Marinez I. Study of Bone Mineral Density in Lumbar Spine and Femoral Neck in a Spanish Population Osteoporosis Int 1997;7:59-64.
3. Díaz Curiel M. Prevalencia de la Osteoporosis Densitométrica en la Población Española. En: Díaz Curiel M, editor. Actualización de Osteoporosis. Madrid: FHOEMO, 2001. p. 3-13.
4. Cabasés JM, Carmona G. Impacto económico de la fractura osteoporótica. Osteoporosis en Atención Primaria 1998;7:5-8
5. O'Neill TW, Felsenbetg D, Varlow L, Cooper C, Kanis JA, Silman AL, EVOS Group: The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporos Study J Bone Miner Res 1996;11:1010-8.
6. Naves ML, Díaz JB, Virgós MJ, et al. Índices de participación y aspectos metodológicos de interés en un estudio de prevalencia de fractura vertebral en Asturias. Rev Esp Enf Metab Óseas 1993;2:149-52.
7. Ismail AA, TW O'Neill, Cooper C, and the European Vertebral Osteoporosis Study Group. Risk factores for vertebral deformities in men: relationship to number of vertebral deformities. J Bone Mineral Res 2000;15:278-83.
8. Center JR, Nguyen TV, Schnider D, et al. Mortality after major types of osteoporotic fracture in men and women. Lancet 1999;353:878-82.
9. Díaz Curiel M. Epidemiología de las fracturas osteoporóticas. Calcif Tissue Int 1992;(Supll):S22-4.
10. Kanis JA. Epidemiología de la fractura de cadera en Europa. El estudio MEDOS. Rev Clin Esp 1991;188(Supp12):16-9.
11. Rapado A, Pérez Cano R, Castro N, et al. Estudio prospectivo epidemiológico sobre las fracturas de cuello del fémur en España. (Proyecto MEDOS) II. Objetivos y desarrollo. Rev Esp Enf Metab Óseas 1992;1:66-8.
12. Sosa M, Segarra MC, Hernández D, González A, Limiñana JM, Betancor P. Epidemiology of Proximal Femoral Fracture in Gran Canaria (Canary Islands). Age Ageing 1993;22:285-8.
13. Seeman E, Melton LJ, O'Fallon WM, et al. Risk factors for spinal osteoporosis in men. Am J Med 1983;75:977-83.
14. Vanderschueren D, Bouillon R. Androgens and bone. Calcif Tissue Int 56;1995:341-6.
15. Wishart JM, Need AG, Horowitz M, Morris A, Nordin BEC. Effect of age on bone density and boen turnover in men. Clin Endocrinology 1995;42:141-6.
16. Murphy S, Khaw K, Cassidy A, Compston JE. Sex hormones and bone mineral density in elderly men. Bone and Mineral 1993;20:133-40.
17. Rapado A, Hawkins F, Sobrinho L, Díaz Curiel M, Galvao-Telles A, Arver S, et al. Bone Mineral density and androgen levels in elderly males. Calcif Tissue Int 1999;65:417-21.
18. Johansson AC, Lindh E, Blum WF, et al. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1996;81:44-8.
19. Martínez Díaz-Guerra G, Hawkins F, Rapado A, Ruiz Díaz MA, Díaz Curiel M. Hormonal and anthropometric predictors of bone mass in healthy men: major effect of sex hormone binding glogulin, parathyroid hormone and body weight. Osteoporos Int 2001;12:178-84.
20. Rapado A, Yague M, Díaz Curiel M. Osteoporosis en el varón. Med Clin 1990;95:389-93.
21. Peris P, Guañabens N, Monegal A, Suris X, et al. Aetiology and presenting symptoms in male osteoporosis Br J Rheumatol 1995;34:936-41.
22. Scane AC, Francis RM. Risk factors for osteoporosis in men. Clin Endocrinol 1993;38:15-6.
23. Slemenda CW, Christian JC, Reed T, Reister TK, Williams CJ, Johnston CC, et al. Long-term bone loss in men: Effects of genetic and environmental factors. Ann Int Med 1992;177:286-91.
24. Need AG, Wishart JM, Scopacasa F, Horowitz M, et al. Effect ofphysical activitid on femeral bone density in men. Br Med J 1995;310:1501-2.
25. Orwoll E, Ettinger M, Weiss S, Miller P, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000;343:604-11.
26. Orwoll E, Scheele WH, Paul S, Adami S, et al. Brief therapy with recombinant human parathyroid hormone (1-34) increases lumbar spine bone mineral density in men with idiopathic or hypogonadal osteoporosis. J Bone Miner Res 2001;(Suppl 1), S221, (Abstract F 393).